GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Price-to-Owner-Earnings

T2 Biosystems (FRA:3T2) Price-to-Owner-Earnings : (As of May. 24, 2025)


View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Price-to-Owner-Earnings?

As of today (2025-05-24), T2 Biosystems's share price is €0.25. T2 Biosystems does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for T2 Biosystems's Price-to-Owner-Earnings or its related term are showing as below:


FRA:3T2's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 26.55
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-24), T2 Biosystems's share price is €0.25. T2 Biosystems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-5.89. Therefore, T2 Biosystems's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-24), T2 Biosystems's share price is €0.25. T2 Biosystems's EPS without NRI for the trailing twelve months (TTM) ended in was €-5.97. Therefore, T2 Biosystems's PE Ratio without NRI for today is At Loss.


T2 Biosystems Price-to-Owner-Earnings Historical Data

The historical data trend for T2 Biosystems's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Price-to-Owner-Earnings Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

T2 Biosystems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of T2 Biosystems's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, T2 Biosystems's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Price-to-Owner-Earnings falls into.


;
;

T2 Biosystems Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

T2 Biosystems's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.25/-3.49
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


T2 Biosystems  (FRA:3T2) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


T2 Biosystems Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

T2 Biosystems Headlines

No Headlines